Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL821842 | 0.94 | GPR84 (0.52) | ACHEGPR84FFAR1NAAAMGLL | |
| SCHEMBL3790426 | 0.92 | GPR84 (0.55) | ACHEGPR84FFAR1NAAAMEN1 | |
| SCHEMBL13658517 | 0.92 | GPR84 (0.55) | ACHEGPR84FFAR1NAAAMEN1 | |
| SCHEMBL957003 | 0.92 | GPR84 (0.55) | ACHEGPR84FFAR1NAAAMEN1 | |
| SCHEMBL822393 | 0.92 | GPR84 (0.55) | ACHEGPR84FFAR1NAAAMEN1 | |
| Ethylene SCHEMBL299575 | 0.89 | GPR84 (0.52) | ACHEGPR84FFAR1TSHRNAAA | |
| SCHEMBL27844490 | 0.89 | ACHE (0.49) | ACHEGPR84FFAR1CA1CA2 | |
| SCHEMBL821952 | 0.88 | ACHE (0.41) | ACHEGPR84FFAR1TSHRNAAA | |
| SCHEMBL4717732 | 0.88 | GPR84 (0.47) | GPR84FFAR1CA1CA2TSHR | |
| SCHEMBL3018221 | 0.88 | ALDH1A1 (0.52) | GPR84FFAR1CA1CA2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119076056-A | Green and efficient esterification catalyst with high hydroxy acid affinity, and preparation method and application thereof | 浙江恒逸石化研究院有限公司 | 2024-12-06 | — | — | CN | disclosed |
| US-20110287102-A1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2011-11-24 | — | — | US | disclosed |
| US-20110287102-A1 | CHAIN EXTENDERS | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110287102-A1 | CHAIN EXTENDERS | UMPS, PUF60, SMCHD1 | ACHE 4438/4885GPR84 1329/4885FFAR1 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.